AbL Diagnostics Valuation
| ABLD Stock | 2.40 0.10 4.00% |
Based on Macroaxis valuation methodology, the firm appears to be undervalued. AbL Diagnostics SA shows a prevailing Real Value of USD2.52 per share. The current price of the firm is USD2.4. Our model approximates the value of AbL Diagnostics SA from analyzing the firm fundamentals such as Shares Outstanding of 2.01 M, return on equity of -0.0612, and Current Valuation of 26.3 M as well as examining its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that AbL Diagnostics' price fluctuation is slightly risky at this time. Calculation of the real value of AbL Diagnostics SA is based on 3 months time horizon. Increasing AbL Diagnostics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since AbL Diagnostics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of AbL Stock. However, AbL Diagnostics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.4 | Real 2.52 | Hype 2.4 |
The real value of AbL Stock, also known as its intrinsic value, is the underlying worth of AbL Diagnostics SA Company, which is reflected in its stock price. It is based on AbL Diagnostics' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of AbL Diagnostics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of AbL Diagnostics SA helps investors to forecast how AbL stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of AbL Diagnostics more accurately as focusing exclusively on AbL Diagnostics' fundamentals will not take into account other important factors: AbL Diagnostics Total Value Analysis
AbL Diagnostics SA is presently forecasted to have takeover price of 26.3 M with market capitalization of 23.76 M, debt of 0, and cash on hands of 2.7 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the AbL Diagnostics fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
26.3 M | 23.76 M | 0 | 2.7 M |
AbL Diagnostics Asset Utilization
One of the ways to look at asset utilization of AbL is to check how much profit was generated for every dollar of assets it reports. AbL Diagnostics SA shows a negative utilization of assets of -0.0402 percent, losing USD4.02E-4 for each dollar of assets held by the firm. Inefficient asset utilization signifies that the company is being less competent with each dollar of assets it shows. Put another way, asset utilization of AbL Diagnostics SA shows how inadequate it operates for each dollar spent on its assets.AbL Diagnostics Ownership Allocation
The market capitalization of AbL Diagnostics SA is USD23.76 Million. AbL Diagnostics SA shows 12.08 percent of its outstanding shares held by insiders and 0.0 percent owned by other corporate entities. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the firm is less than the current market value, you may not be able generate positive returns on investment in the long run.AbL Diagnostics Profitability Analysis
Net Income was 257.87 K with loss before overhead, payroll, taxes, and interest of (101.62 K).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates AbL Diagnostics' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in AbL Diagnostics and how it compares across the competition.
About AbL Diagnostics Valuation
The stock valuation mechanism determines AbL Diagnostics' current worth on a weekly basis. Our valuation model uses a comparative analysis of AbL Diagnostics. We calculate exposure to AbL Diagnostics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of AbL Diagnostics's related companies.8 Steps to conduct AbL Diagnostics' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates AbL Diagnostics' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct AbL Diagnostics' valuation analysis, follow these 8 steps:- Gather financial information: Obtain AbL Diagnostics' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine AbL Diagnostics' revenue streams: Identify AbL Diagnostics' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research AbL Diagnostics' industry and market trends, including the size of the market, growth rate, and competition.
- Establish AbL Diagnostics' growth potential: Evaluate AbL Diagnostics' management, business model, and growth potential.
- Determine AbL Diagnostics' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate AbL Diagnostics' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for AbL Stock analysis
When running AbL Diagnostics' price analysis, check to measure AbL Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbL Diagnostics is operating at the current time. Most of AbL Diagnostics' value examination focuses on studying past and present price action to predict the probability of AbL Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbL Diagnostics' price. Additionally, you may evaluate how the addition of AbL Diagnostics to your portfolios can decrease your overall portfolio volatility.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |